NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02319187,Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial,https://clinicaltrials.gov/study/NCT02319187,,UNKNOWN,"Esophageal cancer is a highly aggressive malignancy with a poor overall outcome.

The purpose of this study is to evaluate the progression free survival and safety of irinotecan plus S1 versus S1 alone in the patients with previously treated advanced esophageal cancer",NO,Esophageal Neoplasms,DRUG: S1|DRUG: S-1|DRUG: irinotecan,"progression free survival, 2","Adverse Events, 2 year|overall survival, 3 year|response rate, 1.5 year|quality of life, 2 year",,Chinese Academy of Medical Sciences,,ALL,"ADULT, OLDER_ADULT",PHASE3,240,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,CH-GI-064,2014-12,2016-12,2017-06,2014-12-18,,2015-08-03,"Hebei four Hospital, Shijiazhuang, Hebei, China|The First Affiliated Hospital of Xinxiang Medical College, Xinxiang, Henan, China|The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China|Tongji Hospital, Tongji Medical College, Wuhan, Hubei, China|Mongolia Chifeng Hospital, Chifeng, Inner Mongolia, China|Ordos Central Hospital, Ordos, Inner Mongolia, China|Jiangsu Taizhou peoples Hospital, Taizhou, Jiangsu, China|Qinghai Cancer Hosptal, Xining, Qinghai, China|Shanxi Province Cancer Hospital, Taiyuan, Shanxi, China|Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, 100021, China|Hunan Cancer Hospital,the Affiliated Cancer Hospital of Xianya School of Medicine, Changsha, China|Herbin Medical University Cancer Hospital, Herbin, China|Henan Cancer Hospital, Zhengzhou, China",
